Skip to main content
OpenTrials
Completed

NCT Number: NCT04588935

Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

To develop a method of medical prevention of cardiovascular diseases caused by cardiotoxicity against the background of complex treatment of patients with primary resectable breast cancer to reduce the risk of cardiovascular complications

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Women With Breast Cancer

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Primary location

Scientific and Practice Center of Cardiology

Minsk, 220000, Belarus

About this study

Purpose of the study: to develop a method of medical prevention of cardiovascular diseases caused by cardiotoxicity against the background of complex treatment of patients with primary resectable breast cancer to reduce the risk of cardiovascular complications

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women with breast cancer, with a morphologically confirmed diagnosis before the appointment of anticancer therapy.

Exclusion criteria

  • presence of other oncological diseases

Treatment and study plan

Bisoprolol; Perindopril;

Drug

based on the results of the patient study, different drug therapy regimens for cardiovascular complications during chemotherapy will be proposed

Other names: Bisoprolol; Perindopril

Primary outcomes

  1. development of cardiovascular diseases and complications

    Time frame: 4 years

    hypertension, cardiomyopathy, arrhythmia's, myocardial infarction, heart failure

Sponsors and collaborators

Lead sponsor

State Institution "Republican Scientific and Practical Center" Cardiology, Belarus

Other

Registry information

Official study title

To Develop and Implement a Method for Medical Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

Important dates

Study start
2019
Primary completion
2023
Study completion
2023
First posted
Oct 19, 2020
Registry last updated
Feb 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.